Fertility Sparing in Endometrial Cancer

Endometrial cancer is the most common gynecological neoplasm with an increased incidence in the premenopausal population in recent decades. This raises the problem of managing endometrial cancer in fertile women who have not yet achieved pregnancy. In these women, after careful selection, hysterecto...

Descripción completa

Detalles Bibliográficos
Autores: Centini, G.|||0000-0002-6113-7401, Colombi, I., Ianes, I., Perelli, F.|||0000-0002-5508-0875, Ginetti, A., Cannoni, A., Habib, Nassir|||0000-0003-3263-553X, Rovira Negre, Ramon|||0000-0003-4136-4153, Martire, F.G.|||0000-0002-0756-535X, Raimondo, D.|||0000-0002-3235-4378, Lazzeri, L., Zupi, E.
Tipo de recurso: artículo
Fecha de publicación:2025
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:320382
Acceso en línea:https://ddd.uab.cat/record/320382
https://dx.doi.org/urn:doi:10.3390/cancers17010112
Access Level:acceso abierto
Palabra clave:Endometrial cancer
Fertility sparing
Uterine neoplasms
Descripción
Sumario:Endometrial cancer is the most common gynecological neoplasm with an increased incidence in the premenopausal population in recent decades. This raises the problem of managing endometrial cancer in fertile women who have not yet achieved pregnancy. In these women, after careful selection, hysterectomy may be postponed in favor of conservative management if specific requirements are met. The latest evidence is focused on early endometrial carcinoma, endometrioid histotype, Grading 1, with no evidence of myometrial infiltration. Few clinical trials have opened this possibility also for women with an endometrial cancer Grading 2 diagnosis. There are still questions about the best medical therapy, dosage, route, and duration of treatment. Oral progestins or levonorgestrel-releasing intrauterine devices appear to be the options associated with the best outcome in terms of complete response and lower recurrence rates. Other options include the use of GnRH analogues, surgical hysteroscopy, or metformin, in a therapeutic approach that takes into account the characteristics of the patient. The pursuit of pregnancy should start as soon as two consecutive endometrial biopsies are obtained 3 months apart from each other; it is recommended to refer the patients to ART centers to maximize the success rate. After having reached the fulfillment of the reproductive desire, surgical radical treatment is still recommended.